Re: Recent findings point to BET protein and ACE2 inhibition as possible means to slow and reduce the impact of COVID-19....
posted on
Mar 24, 2020 09:33AM
Thanks for this Bear " "
"Resverlogix and Zenith combined have thousands of compounds. Not all are the same. Different selectivities for BD1 vs BD2, for the different BET bromodomain proteins (BRD2, BRD3, BRD4, etc.), different modes of inhibition (competitive vs. covalent/suicide)."
" there is enormous potential in those compound libraries,"
+ BTD + now a Potential Player in Covid 19 etc etc & hunreds of mllions spent
Break it down based on compounds alone & the market has us valued at about 1/10th of a penny per compound,less if we have more than a thousand.hummmmmmm crazy IMO